Insider Trading Summary for October 4, 2024

This article summarizes the most significant insider buying and selling activities for US stocks reported on Friday, October 4, 2024.

Top Insider Buys:

• Oncocyte Corp (NYSEAMERICAN:OCX): Broadwood Partners L.P. increased its stake by purchasing 1,315,339 shares at an average price of $2.948 per share, totaling approximately $3.88 million. This acquisition boosts their ownership to 6,244,405 shares.

• Cartesian Therapeutics, Inc. (NASDAQ:RNAC): Director Timothy A. Springer made stock purchases totaling approximately $4.29 million, including a single-day purchase of 48,880 shares at an average price of $22.3542, signaling a bullish outlook on the company.

• Armour Residential REIT, Inc. (NYSE:ARR): Chairman Daniel C. Staton acquired 10,000 shares for $198,570, indicating confidence in the company’s future prospects.

Top Insider Sells:

• Apogee Therapeutics, Inc. (NASDAQ:APGE): CEO Michael Thomas Henderson sold 40,000 shares at prices between $56.07 and $56.74, totaling over $2.2 million, executed under a Rule 10b5-1 trading plan.

• AutoZone Inc. (NYSE:AZO): Executive Chairman William C. Rhodes III sold shares in two transactions; the first involved 2,135 shares for $7.56 million, and the second exceeded $39 million.

• Cloudflare, Inc. (NYSE:NET): CFO Thomas J. Seifert sold 15,000 shares valued at approximately $1,187,865, with prices between $78.21 to $79.81 per share.

• Lowe’s Companies Inc. (NYSE:LOW): EVP Seemantini Godbole sold 26,186 shares at $271.73 each, totaling about $7.12 million, alongside option exercises on the same date.

Investors should monitor insider trading as an insight into a company’s internal perspective. Although insider transactions should not dictate investment decisions alone, they are valuable in conjunction with financial analysis and market research. It’s also crucial to understand that insiders have various reasons for their trades, and these activities should form part of a comprehensive investment strategy.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.